Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Mid-Sized European Companies Eager to Acquire During Growth Spurt

Executive Summary

Among Europe’s flourishing niche of mid-sized pharmaceutical companies, Italy’s Recordati and Spain’s Almirall have snapped up smaller local companies during the past six to nine months, while Switzerland’s Actelion is concentrating on executing new product launches while considering M&A.


Related Content

Actelion Could Succumb To Big Pharma's Charms
Actelion's Opsumit Shows MERIT In CTEPH
Sun Builds On Tildrakizumab Hopes With Almirall Pact
PIPELINE WATCH: Five Approvals, Four Filings And Two Launches
PIPELINE WATCH - Three Approvals, Four Filings, And Three Orphan Drug Designations
Actelion's Tracleer Hangs On, Uptravi Launch Begins
Almirall Strikes Again In Derma


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst